[Abstract]:

On July 10, 2020, the official website of the State Food and Drug Administration of the people's Republic of China issued a reply from the State Administration to Shandong drug administration, which clarified the identification of API in the new drug administration law.

According to the reply, the Constitution and Law Committee of the National People's Congress pointed out in its report on the results of deliberation on the drug administration law of the people's Republic of China (Revised Draft), the revised draft lists the types of drugs in the definition of drugs in a general form according to the classification of drugs recognized by all parties. API is still under drug administration and shall comply with the provisions of the drug administration law.